Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylaxis versus on-demand Kogenate Bayer in young adults with severe hemophilia A
2005-002757-45Phase 4Completed
- Sponsor
- Bayer
- Start
- Sep 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Factor VIII in hemophilia A, sponsored by Bayer. Primary endpoint: Number of joint bleeds. Started Sep 2005; status: completed.
02
Drugs
Factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2005-002757-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002757-45.